Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Food and Drug Administration WADA 2025 Prohibited List PDF (S0 unapproved substances class includes BPC157)
Research has studied BPC-157 in models of gastric ulceration, inflammatory bowel conditions, and intestinal anastomosis, investigating its cytoprotective properties and interactions with the gut lining at the cellular level
This eliminates injection requirements for certain applications while maintaining therapeutic effects
Long-term clinical trials with diverse patient populations are vital for evaluating therapies that target cellular metabolism
Systemic effects documented in animal studies -- lung tissue protection, neurological effects, joint healing -- are not achievable through topical application
We cover the B12 side in more depth in our guide to MIC B12 injections and weight loss shots
